According to a new report, published by KBV research, The Global Apheresis Market size is expected to reach $4 billion by 2028, rising at a market growth of 8.1% CAGR during the forecast period.
The Therapeutic segment is showcasing a CAGR of 9.6% during (2022 - 2028). Apheresis is frequently performed on donors, in which whole blood is centrifuged to acquire individual blood components red blood cells [RBCs], platelets, and plasma-based on particular gravity for transfusion in various patients. Apheresis can also be used to treat a variety of disorders. Plasma exchange and cytapheretic are examples of therapeutic apheresis.
The Disposable & Reagents segment acquired maximum revenue share in the Global Apheresis Market by Product in 2021; thereby, achieving a market value of $2.1 billion by 2028. The manufacture of disposable kits, blood bags, and tubes has undergone significant developments. For an immunoadsorption (IA) or therapeutic plasma exchange (TPE) therapy on the LIFE 21 or LIFE 18 apheresis device, disposable sets include single-use tube sets, solutions, and accessories such as filters.
The Membrane Separation segment has shown growth rate of 8.2% during (2022 - 2028). It is because, membrane filters are critical in separating the blood from other cellular components to meet desired cell separation. Blood components are differentiated based on size differences in membrane-based apheresis. Membranes are created with pore sizes large enough to separate the blood portion of interest while preserving other relevant components.
The Blood Centers segment is leading the Global Apheresis Market by End User in 2021, thereby, achieving a market value of $1.94 billion by 2028. This is due to donor apheresis being a chief component of the apheresis industry, with blood centers performing the majority of donor apheresis procedures worldwide. The blood center provides all types of blood including the rare blood which are hard to find in normal audience.
The Platelets (Plateletpheresis) market is experiencing a CAGR of 7.2% during (2022 - 2028). Plateletpheresis is the normal practice for separating, concentrating, and collecting platelets from whole blood. A needle is inserted into each arm to remove platelets. Blood is drawn through a needle into a machine containing a sterile, plastic disposable kit designed specifically for this purpose. Platelets are separated and directed into a special bag, while red blood cells and other components of blood are returned to patient via a syringe in the opposite arm.
The North America market dominated the Global Apheresis Market by Region in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $1,501.6 million by 2028. The Europe market is estimated to witness a CAGR of 7.6% during (2022 - 2028). Additionally, The Asia Pacific market would display a CAGR of 8.5% during (2022 - 2028).
Full Report: https://www.kbvresearch.com/apheresis-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Haemonetics Corporation, Fresenius SE & Co. KGaA, Terumo Corporation, Asahi Kasei Medical Co., Ltd., Kaneka Corporation, Cerus Corporation, B. Braun Melsungen AG, Nikkiso Co., Ltd., Charles River Laboratories International, Inc., and SB Kawasumi Laboratories, Inc.
By Procedure
By Product
By Method
By End User
By Component
By Geography
Companies Profiled
Unique Offerings 
